117 related articles for article (PubMed ID: 28593747)
81. Metabolomics of Breast Cancer: A Review.
Subramani R; Poudel S; Smith KD; Estrada A; Lakshmanaswamy R
Metabolites; 2022 Jul; 12(7):. PubMed ID: 35888767
[TBL] [Abstract][Full Text] [Related]
82. Bioenergetic cellular index: a clinical biomarker to identify metabolic adaption in melanoma?
Armstrong J
Br J Dermatol; 2019 Jul; 181(1):15-16. PubMed ID: 31259409
[No Abstract] [Full Text] [Related]
83. Disease-related biomarkers as experimental endpoints in 3D skin culture models.
Chaturvedi D; Paranjape S; Jain R; Dandekar P
Cytotechnology; 2023 Jun; 75(3):165-193. PubMed ID: 37187945
[TBL] [Abstract][Full Text] [Related]
84. New biomarkers improve stratification of patients with melanoma.
Craig S; Virós A
Br J Dermatol; 2020 Jan; 182(1):5-6. PubMed ID: 31894877
[No Abstract] [Full Text] [Related]
85. Correction to: A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer.
Neumann JM; Niehaus K; Neumann N; Knobloch HC; Bremmer F; Krafft U; Kellner U; Nyirády P; Szarvas T; Bednarz H; Reis H
Lab Invest; 2021 Oct; 101(10):1414. PubMed ID: 34155317
[No Abstract] [Full Text] [Related]
86. Cell biology: Healthy skin rejects cancer.
Burclaff J; Mills JC
Nature; 2017 Aug; 548(7667):289-290. PubMed ID: 28783724
[No Abstract] [Full Text] [Related]
87. The triple response of Lewis.
KONG LN
Med Bull (Ann Arbor); 1960 Dec; 26():445-50. PubMed ID: 13752944
[No Abstract] [Full Text] [Related]
88. Observations on the Sebacic Acid.
Thenars
Med Phys J; 1803 Jan; 9(47):78-79. PubMed ID: 30491476
[No Abstract] [Full Text] [Related]
89. High-throughput lipidomic profiles sampled with electroporation-based biopsy differentiate healthy skin, cutaneous squamous cell carcinoma, and basal cell carcinoma.
Louie L; Wise J; Berl A; Shir-Az O; Kravtsov V; Yakhini Z; Shalom A; Golberg A; Vitkin E
Skin Res Technol; 2024 May; 30(5):e13706. PubMed ID: 38721854
[TBL] [Abstract][Full Text] [Related]
90. Promising Markers of Inflammatory and Gut Dysbiosis in Patients with Post-COVID-19 Syndrome.
Sorokina E; Pautova A; Fatuev O; Zakharchenko V; Onufrievich A; Grechko A; Beloborodova N; Chernevskaya E
J Pers Med; 2023 Jun; 13(6):. PubMed ID: 37373960
[TBL] [Abstract][Full Text] [Related]
91. MACdb: A Curated Knowledgebase for Metabolic Associations across Human Cancers.
Sun Y; Zheng X; Wang G; Wang Y; Chen X; Sun J; Xiong Z; Zhang S; Wang T; Fan Z; Bu C; Bao Y; Zhao W
Mol Cancer Res; 2023 Jul; 21(7):691-697. PubMed ID: 37027007
[TBL] [Abstract][Full Text] [Related]
92. Current Knowledge in Skin Metabolomics: Updates from Literature Review.
Paganelli A; Righi V; Tarentini E; Magnoni C
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955911
[TBL] [Abstract][Full Text] [Related]
93. Clinical Significance of Screening Differential Metabolites in Ovarian Cancer Tissue and Ascites by LC/MS.
Liu M; Liu Y; Feng H; Jing Y; Zhao S; Yang S; Zhang N; Jin S; Li Y; Weng M; Xue X; Wang F; Yang Y; Jin X; Kong D
Front Pharmacol; 2021; 12():701487. PubMed ID: 34795577
[TBL] [Abstract][Full Text] [Related]
94. Novel serum metabolomics-based approach by gas chromatography/triple quadrupole mass spectrometry for detection of human skin cancers: Candidate biomarkers.
Fukumoto T; Nishiumi S; Fujiwara S; Yoshida M; Nishigori C
J Dermatol; 2017 Nov; 44(11):1268-1275. PubMed ID: 28593747
[TBL] [Abstract][Full Text] [Related]
95. Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry.
Nishiumi S; Kobayashi T; Kawana S; Unno Y; Sakai T; Okamoto K; Yamada Y; Sudo K; Yamaji T; Saito Y; Kanemitsu Y; Okita NT; Saito H; Tsugane S; Azuma T; Ojima N; Yoshida M
Oncotarget; 2017 Mar; 8(10):17115-17126. PubMed ID: 28179577
[TBL] [Abstract][Full Text] [Related]
96. Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
Mazzone PJ; Wang XF; Beukemann M; Zhang Q; Seeley M; Mohney R; Holt T; Pappan KL
J Thorac Oncol; 2016 Jan; 11(1):72-8. PubMed ID: 26762741
[TBL] [Abstract][Full Text] [Related]
97. Exploring a Novel Screening Method for Patients with Oral Squamous Cell Carcinoma: A plasma Metabolomics Analysis.
Enomoto Y; Kimoto A; Suzuki H; Nishiumi S; Yoshida M; Komori T
Kobe J Med Sci; 2018 Sep; 64(1):E26-E35. PubMed ID: 30282895
[TBL] [Abstract][Full Text] [Related]
98. Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.
Utikal J; Schadendorf D; Ugurel S
Arch Dermatol Res; 2007 Mar; 298(10):469-77. PubMed ID: 17221215
[TBL] [Abstract][Full Text] [Related]
99.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
